TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
21.62%
1 Year Est. Return
+21.62%
AUM
$1.98B
AUM Growth
+$171M
(+9.4%)
Holding
220
Top Buys
| 1 | +$28.3M | |
| 2 | +$26.3M | |
| 3 | +$22.9M | |
| 4 |
Boeing
BA
|
+$20.9M |
| 5 |
Spyre Therapeutics
SYRE
|
+$17.2M |
Top Sells
| 1 | +$37.7M | |
| 2 | +$29M | |
| 3 | +$24.3M | |
| 4 |
ONC
BeOne Medicines Ltd
ONC
|
+$10.1M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$9.07M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Technology | 1.37% |
| 3 | Industrials | 1.32% |
| 4 | Communication Services | 1.26% |
| 5 | Consumer Discretionary | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Galapagos
GLPG
$2.07B
| $112M | 5.65% |
3,990,111
+28,314
|
|
||
2
Tarsus Pharmaceuticals
TARS
$2.99B
| $99.4M | 5.03% |
2,454,797
|
|
||
3
Aurinia Pharmaceuticals
AUPH
$1.56B
| $84.9M | 4.29% |
10,029,500
|
|
||
4
Immunocore
IMCR
$1.71B
| $66.1M | 3.34% |
2,105,608
+189,900
|
|
||
5
Kiniksa Pharmaceuticals
KNSA
$2.89B
| $64.4M | 3.26% |
2,328,609
+210,030
|
|
||
6
Mirum Pharmaceuticals
MIRM
$3.47B
| $62.9M | 3.18% |
1,236,027
-1,080
|
|
||
7
KalVista Pharmaceuticals
KALV
$583M
| $55.9M | 2.82% |
4,941,798
|
|
||
8
PTC Therapeutics
PTCT
$5.34B
| $53.7M | 2.72% |
1,100,000
+100,000
|
|
||
|
9
Spyre Therapeutics
SYRE
$1.82B
| $47.9M | 2.42% |
3,200,000
+1,150,000
|
|
||
10
Evolus
EOLS
$433M
| $46M | 2.33% |
4,997,399
|
|
||
11
Viridian Therapeutics
VRDN
$1.97B
| $39.7M | 2.01% |
2,842,925
+50,000
|
|
||
|
ITOS
12
DELISTED
iTeos Therapeutics
ITOS
| $38.2M | 1.93% |
3,826,692
+1,137,492
|
|
||
13
Compass Therapeutics
CMPX
$695M
| $35.1M | 1.77% |
13,496,208
+2,443,576
|
|
||
14
Acadia Pharmaceuticals
ACAD
$3.53B
| $32.4M | 1.64% |
1,500,000
|
|
||
15
Vera Therapeutics
VERA
$1.93B
| $31.8M | 1.61% |
1,350,000
+1,200,000
|
|
||
16
Merus
MRUS
$7.16B
| $31.6M | 1.6% |
600,000
+500,000
|
|
||
17
Replimune Group
REPL
$632M
| $29.7M | 1.5% |
3,200,000
+300,000
|
|
||
18
AnaptysBio
ANAB
$987M
| $29.5M | 1.49% |
1,330,879
-214,274
|
|
||
19
Legend Biotech
LEGN
$6.07B
| $29.5M | 1.49% |
830,000
|
|
||
20
BioNTech
BNTX
$26B
| $28.7M | 1.45% |
270,000
|
|
||
21
Relay Therapeutics
RLAY
$1.23B
| $27.9M | 1.41% |
8,068,058
|
|
||
|
LENZ
22
LENZ Therapeutics
LENZ
$1.02B
| $26.3M | 1.33% |
897,616
+130,676
|
|
||
23
CytomX Therapeutics
CTMX
$597M
| $25.1M | 1.27% |
11,065,662
+4,347,837
|
|
||
24
Mettler-Toledo International
MTD
$28B
| $22.9M | 1.16% |
+19,500
|
|
||
|
25
Boeing
BA
$164B
| $22.1M | 1.12% |
105,662
+99,594
|
|